Nuvation Bio Inc.·4

Nov 13, 4:28 PM ET

Wang Junyuan Jerry 4

4 · Nuvation Bio Inc. · Filed Nov 13, 2024

Insider Transaction Report

Form 4
Period: 2024-11-11
Wang Junyuan Jerry
DirectorCEO, ANHEART THERAPEUTICS LTD.
Transactions
  • Sale

    Class A Common Stock

    2024-11-11$2.89/sh56,361$162,8833,866,228 total
Holdings
  • Class A Common Stock

    (indirect: By LLC)
    2,246,458
Footnotes (2)
  • [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
  • [F2]Shares are held directly by WangWang, LLC, of which the Reporting Person is Manager.

Documents

1 file
  • 4
    form4-11132024_091128.xmlPrimary